The Federal Government has announced plans to introduce Lenacapavir, a long-acting injectable drug for the prevention of HIV, into Nigeria in March 2026, in a move health authorities say could significantly strengthen the country’s fight against new infections.
The development was disclosed by the National Agency for the Control of AIDS, which confirmed that the breakthrough medication has secured regulatory approval from the National Agency for Food and Drug Administration and Control.